Dr. Willi Schnorpfeil has more than 15 years business experience in the German health care sector. As an economist, his main focus has been on Market Access and Reimbursement of pharmaceuticals and medicinal products. He is one of the rare Consultants in Germany who has worked in management positions in the pharmaceutical industry as well as for health insurances. Hence, Dr. Willi Schnorpfeil has gained a lot of negotiation expertise and experience from both sides of the table.
Today, Dr. Willi Schnorpfeil is working as Consultant for Market Access and Reimbursement of pharmaceuticals and medical devices.
The last health care Reform - AMNOG - which became effective January 1st 2011, has introduced for the first time Price negotiations for new, patent protected drugs based on a systematic benefit assessment in Germany. All of the issues around Market Access, Reimbursement and Negotiations of drugs and medical devices in Germany and Europe are the core Business of my consultancy.
My services include consultancy on:
Market Access and Reimbursement
- For drugs and medical products
- Reimbursement application for the hospital and outpatient sector
- Preparation of Value Dossiers
Health Economics and Outcome Research
- Benefit- and Cost-Benefit-Assessment
- Pricing and fix price calculation
- Health economic modelling and Budget Impact Analysis
Contracting and Managed Care
- Training and Coaching
- Negotiation Management
- Simulation of drug tenders
Communication and Issue Management
- Stakeholder / KOL Management
- Strategic Consulting and Communication
Please feel free to contact me: +49 (0)170 620 48 43 / +49 (0) 6173 3949306!